Clinical Trials Logo

Oral Manifestations clinical trials

View clinical trials related to Oral Manifestations.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05549648 Completed - Oral Manifestations Clinical Trials

The Oral Biomechanical Functions of Hong Kong Healthy Adults

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Hong Kong and Japan are similar in terms of facing the super-ageing society. Maintaining oral function in elderly is particularly important because it affects social, physical and mental health to the people and to the society. By using technology seems to be one of the solutions in dealing with this. Thus, this project aims at using state-of-the-art Age-tech that have been used in Japan to implement "Oral Frailty" concept in Hong Kong. Through identifying oral biomechanical in elderly population, the investigators expect the situation can be improved, and the data analysed and collected can be useful and impactful that can influence the dental communities around Southeast Asia and the globe.

NCT ID: NCT05540171 Completed - Quality of Life Clinical Trials

An Educational Intervention Program to Improve the Oral Health of HIV-Positive Children in Kano, Nigeria.

Start date: December 22, 2022
Phase: N/A
Study type: Interventional

The aim of this 2- arm randomized-control study is to determine the effect of an oral hygiene self care intervention on the oral health status and oral health-related quality of life (OHRQoL) of HIV-positive children (age: 8-16 years, n=172) presenting to five pediatric HIV clinics in Kano, Nigeria. The intervention will comprise oral health education and instructions on oral self-care. Data on oral health status and OHRQoL will be obtained at baseline and at 1, 3 and 6 months. Study findings will help inform policies to improve the oral health and OHRQoL of HIV-positive Nigerian children and guide the integration of oral health care services into HIV programs.

NCT ID: NCT04893694 Completed - SARS-CoV2 Infection Clinical Trials

the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection

Start date: May 20, 2021
Phase:
Study type: Observational

The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore, cells with ACE2 receptor distribution may become host cells for the virus and cause inflammatory response in related organs and tissues, such as the tongue mucosa and salivary glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection

NCT ID: NCT04821986 Completed - SARS-CoV Infection Clinical Trials

Oral Manifestation in Patients With SARS-CoV2 Infection.

Start date: April 1, 2021
Phase:
Study type: Observational

The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands and soft tissues Moreover, oral mucosa can be affected by secondary pathological process of a bacterial or fungal nature due to viral immunosuppression. The oral cavity could be considered a "biological barometer" of both viral infection and viral immunosuppression advancement .

NCT ID: NCT04812990 Completed - Hepatitis C Clinical Trials

A Cross Sectional Observational Study on Relation Between Oral Manifestation and Hepatitis C in Egypt

Start date: March 1, 2021
Phase:
Study type: Observational

Hepatitis C virus (HCV) is the major cause of chronic liver disease and has a long-term resultant complications4 and it considered as a major endemic medical health problem in Egypt. It affects multiple organs and reflect various manifestations on oral cavity.The purpose of this study is to assess the prevalence of oral mucosa conditions, type of oral manifestation and gingival lesions in patients with hepatitis C

NCT ID: NCT04056559 Completed - Oral Manifestations Clinical Trials

Normative Assessment of Adaptable Mouthguards.

ENORMPIBA
Start date: September 9, 2011
Phase: N/A
Study type: Interventional

The aim of this study is to the validate adaptable mouthguards prototypes, patented by Bordeaux University and Bordeaux University Hospital.

NCT ID: NCT03365570 Completed - Clinical trials for Iron Deficiency Anemia

Prevalence of Oral Manifestations of Iron Deficiency Anemia in a Sample of Egyptian Population

Start date: May 1, 2018
Phase:
Study type: Observational

According to WHO Reportin 2002, iron deficiency anemia was considered to be the most important contributing factor to the global burden of anemia. Children and women in reproductive ages are more at risk factor for developing iron deficiency anemia.No previous study has been held to assess prevalence of oral manifestations of iron deficiency anemia as a hospital-based cross-sectional study on a sample of Egyptian patients in hematology department (no previous data recorded).

NCT ID: NCT01699412 Completed - Clinical trials for Graft vs Host Disease

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to perform a randomized, double-blind, clinical trial comparing the topical treatment with clobetasol or dexamethasone for symptomatic oral lesions of chronic graft-versus-host disease.

NCT ID: NCT01156376 Completed - Oral Manifestations Clinical Trials

Oral Irritation Study of Two Experimental Mouthrinses

Start date: June 2010
Phase: N/A
Study type: Interventional

This study is 25 days long. People participating in this study will be asked to brush their teeth two times a day. People will be assigned to a mouthwash and will rinse four times a day at the site for five days. A dentist or dental hygienist will look at the mouth, teeth, tongue and gums to make sure the mouthwash does not irritate the mouth. After Day 5 of the study, people will continue to brush two times a day and will return on Day 24 to have their mouth looked at again. People without irritation in their mouth will rinse 4 times a day at the clinical site. People will return to the clinical site the next day and have a final oral exam in which the dentist or dental hygienist will look at the mouth for irritation.

NCT ID: NCT00006300 Completed - Aplastic Anemia Clinical Trials

Oral Manifestations of Aplastic Anemia

Start date: April 2000
Phase: N/A
Study type: Observational

The purposes of this study are threefold: 1) to evaluate the prevalence and risks of oral complications in patients with aplastic anemia; 2) to evaluate if oral problems in these patients can predict their response to treatment; and 3) to review complications of dental treatment in these patients in order to establish treatment guidelines. This study will be performed through a review of medical charts of 79 patients with aplastic anemia and 67 patients with schizophrenia who were treated at the National Institutes of Health Dental Clinic between 1993 and 1999. The schizophrenia patients will serve as a control population. Demographic, clinical and radiographic information will be collected for all patients. Additional data collected only for aplastic anemia patients will include medical therapy, disease duration, blood cell counts, oral problems that developed during treatment and treatment response.